D. Bullough

发表

Modulation of cardiac remodeling by adenosine: In vitro and in vivo effects

M. Erion, F. Villarreal, B. Ito, 2003, Molecular and Cellular Biochemistry.

Dual activation of adenosine A1 and A3 receptors mediates preconditioning of isolated cardiac myocytes.

G. Firestein, K. Mullane, D. Bullough, 1997, European journal of pharmacology.

Knock-Down of IL-1Ra in Obese Mice Decreases Liver Inflammation and Improves Insulin Sensitivity

S. Schenk, M. Maris, Saswata Talukdar, 2014, PloS one.

Harnessing an endogenous cardioprotective mechanism: cellular sources and sites of action of adenosine.

K. Mullane, D. Bullough, K. Mullane, 1995, Journal of molecular and cellular cardiology.

Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes.

G. Firestein, K. Mullane, D. Bullough, 1995, Journal of immunology.

Acadesine and Myocardial Protection: Studies of Time of Administration and Dose‐Response Relations in the Rat

K. Mullane, D. Hearse, D. Bullough, 1992, Circulation.

From academic vision to clinical reality A case study of acadesine.

D. Bullough, K. Mullane, D. Shapiro, 1993, Trends in cardiovascular medicine.

Liver-Targeted Drug Delivery Using HepDirect1 Prodrugs

M. Erion, P. D. van Poelje, D. Mackenna, 2005, Journal of Pharmacology and Experimental Therapeutics.

Characterization of arbutamine: A novel catecholamine stress agent for diagnosis of coronary artery disease

K. Mullane, Wei-Han Pan, D. Bullough, 1994 .

Separate beta subunits are derivatized with 14C and 3H when the bovine heart mitochondrial F1-ATPase is doubly labeled with 7-chloro-4-nitro[14C]benzofurazan and 5'-p-fluorosulfonylbenzoyl[3H]inosine.

W. Allison, S. Zhuo, D. Bullough, 1991, Biochimica et biophysica acta.

Identification of essential residues in the F1-ATPases by chemical modification.

W. Allison, D. Bullough, W. W. Andrews, 1986, Methods in enzymology.

Sustained Protection by Acadesine Against Ischemia‐ and Reperfusion‐Induced Injury: Studies in the Transplanted Rat Heart

K. Mullane, D. Hearse, D. Bullough, 1992, Circulation.

The varied responses of different F1-ATPases to chlorpromazine.

M. Yoshida, W. Allison, D. Bullough, 1985, Archives of biochemistry and biophysics.

HepDirect prodrugs for targeting nucleotide-based antiviral drugs to the liver.

M. Erion, Z. Hong, Chin-chung Lin, 2006, Current opinion in investigational drugs.

Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo.

K. Mullane, A. Montag, D. Bullough, 1994, The Journal of clinical investigation.

Preclinical Pharmacokinetics of a HepDirect Prodrug of a Novel Phosphonate-Containing Thyroid Hormone Receptor Agonist

M. Erion, P. D. van Poelje, E. Cable, 2008, Drug Metabolism and Disposition.

Inhibition of the bovine-heart mitochondrial F1-ATPase by cationic dyes and amphipathic peptides.

E. Ceccarelli, W. Allison, D. Roise, 1989, Biochimica et biophysica acta.

The isolation and purification of the elvapeptins

P. Henderson, P. Linnett, D. Bullough, 1982 .

Gene activation of SMN by selective disruption of lncRNA-mediated recruitment of PRC2 for the treatment of spinal muscular atrophy

B. Mandefro, Brian E. Schwartz, J. Barsoum, 2017, Proceedings of the National Academy of Sciences.

Protection against injury during ischemia and reperfusion by acadesine derivatives GP-1-468 and GP-1-668. Studies in the transplanted rat heart.

M. Galiñanes, D. Hearse, D. Bullough, 1995, The Journal of thoracic and cardiovascular surgery.

Protective effect of an adenosine kinase inhibitor in septic shock.

G. Firestein, D. Boyle, K. Mullane, 1994, Journal of immunology.

Inactivation of the bovine heart mitochondrial F1-ATPase by 5'-p-fluorosulfonylbenzoyl[3H]inosine is accompanied by modification of tyrosine 345 in a single beta subunit.

W. Allison, D. Bullough, 1986, The Journal of biological chemistry.

Inactivation of the F1-ATPase from the thermophilic bacterium PS3 by 5′-p-fluorosulfonylbenzoylinosine at 65° C is accompanied by modification of β-tyrosine-364

W. Allison, D. Bullough, 1988 .

Acadesine (AICA riboside) inhibits platelet aggregation in human whole blood.

K. Mullane, D. Bullough, C. Zhang, 1991, Advances in experimental medicine and biology.

Acadesine Reduces the Frequency of Coronary Artery Reocclusion Following rt-PA Induced Thrombolysis in the Dog

K. Mullane, D. Bullough, Mark Young, 1995, Thrombosis and Haemostasis.

Cardioprotection with a novel adenosine regulating agent mediated by intravascular adenosine.

K. Mullane, C. Buggé, D. Bullough, 1997, European journal of pharmacology.

Three copies of the beta subunit must be modified to achieve complete inactivation of the bovine mitochondrial F1-ATPase by 5'-p-fluorosulfonylbenzoyladenosine.

W. Allison, D. Bullough, 1986, The Journal of biological chemistry.

Evidence for functional heterogeneity among the catalytic sites of the bovine heart mitochondrial F1-ATPase.

W S Allison, M. Yoshida, W. Allison, 1987, The Journal of biological chemistry.

Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins.

M. Erion, C. Smith, G. Firestein, 1995, Journal of immunology.

Heterogeneous hydrolysis of substoichiometric ATP by the F1-ATPase from Escherichia coli.

E. Muneyuki, M. Yoshida, W. Allison, 1991, Biochimica et biophysica acta.

Carbohydrate- and CD18-dependent neutrophil adhesion to cardiac myocytes: effects of adenosine.

G. Firestein, K. Mullane, D. Bullough, 1996, Cardiovascular research.

Acadesine (AICA riboside) attenuates reperfusion injury and oxidant-induced damage of the heart.

K. Mullane, D. Bullough, S. Potter, 1991, Advances in Experimental Medicine and Biology.

Sequence of the radioactive tryptic peptide obtained after inactivating the F1-ATPase of the thermophilic bacterium PS3 with 5'-p-fluorosulfonylbenzoyl[3H]adenosine at 65 degrees C.

M. Yoshida, W. Allison, D. Bullough, 1986, Archives of biochemistry and biophysics.